Skip to content
10-Q

Quarterly Report

BARINTHUS BIOTHERAPEUTICS PLC BRNS

0001828185-25-000059

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 40.72M sh
Shares Diluted Q2 2025 · Jun 30, 2025 40.34M sh
Shares Diluted Q2 2025 · Jun 30, 2025 40.3M sh
Shares Diluted Q2 2025 · Jun 30, 2024 39.04M sh
Shares Diluted Q2 2025 · Jun 30, 2024 38.91M sh
Capex Q2 2025 · Jun 30, 2025 $37K
Capex Q2 2025 · Jun 30, 2024 $500K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$33.01M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$23.83M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $86.26M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $110.66M
Stockholders Equity Q2 2025 · Jun 30, 2025 $102.38M
Stockholders Equity Q2 2025 · Dec 31, 2024 $130.03M
Current Liabilities Q2 2025 · Jun 30, 2025 $12.73M
Current Liabilities Q2 2025 · Dec 31, 2024 $15.66M
Total Liabilities Q2 2025 · Jun 30, 2025 $27.08M
Total Liabilities Q2 2025 · Dec 31, 2024 $30.19M
Current Assets Q2 2025 · Jun 30, 2025 $100.41M
Current Assets Q2 2025 · Dec 31, 2024 $125.74M
Total Assets Q2 2025 · Jun 30, 2025 $129.56M
Total Assets Q2 2025 · Dec 31, 2024 $160.33M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.52
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.01
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.43
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.83
Eps Basic Q2 2025 · Jun 30, 2025 −$0.52
Eps Basic Q2 2025 · Jun 30, 2025 −$1.01
Eps Basic Q2 2025 · Jun 30, 2024 −$0.43
Eps Basic Q2 2025 · Jun 30, 2024 −$0.83
Sga Expense Q2 2025 · Jun 30, 2025 $15.38M
Sga Expense Q2 2025 · Jun 30, 2025 $28.02M
Sga Expense Q2 2025 · Jun 30, 2024 $7.2M
Sga Expense Q2 2025 · Jun 30, 2024 $13.2M
Rd Expense Q2 2025 · Jun 30, 2025 $7.95M
Rd Expense Q2 2025 · Jun 30, 2025 $16.24M
Rd Expense Q2 2025 · Jun 30, 2024 $11.66M
Rd Expense Q2 2025 · Jun 30, 2024 $22.79M
Net Income Q2 2025 · Jun 30, 2025 −$21.12M
Net Income Q2 2025 · Jun 30, 2025 −$40.77M
Net Income Q2 2025 · Jun 30, 2024 −$16.93M
Net Income Q2 2025 · Jun 30, 2024 −$32.42M
Operating Income Q2 2025 · Jun 30, 2025 −$23.32M
Operating Income Q2 2025 · Jun 30, 2025 −$43.92M
Operating Income Q2 2025 · Jun 30, 2024 −$18.29M
Operating Income Q2 2025 · Jun 30, 2024 −$35.2M